Judges Scientific (JDG:AIM) £102Gain to date: 3.2%We recommended shares in ?buy and build? scientific instrument maker Judges Scientific (JDG:AIM) in February based on the firm?s ability to generate solid earnings growth and the long-term trends underlying its business.WHAT HAS HAPPENED SINCE WE SAID BUY?In March, the company posted record revenue of £136 million for 2023, a 20% increase on the

Judges Scientific (JDG:AIM) £98.82Market cap: £655 millionScience kit manufacturer Judges Scientific (JDG:AIM) has built up a loyal fan base over the years, both ordinary and professional investors. We continue to see the stock as a core smaller company growth holding that will gradually build value for portfolios, while letting you sleep comfortably at night.Over the past 10 years, the stock ha

Melrose CEO dumps 2 million sharesIncoming M&C Saatchi chair buys £249,000 sharesJudges Scientific director cashes in £94,500 sharesSimon Peckham, chief executive of UK manufacturing company Melrose (MRO), sold 2,000,000 shares at 525p for a total value of £10.5 million on 14 June causing the company's share price to slide on the news.The sale, which leaves Peckham with only half his shareholdi

David Gammon, chairman of video games developer and publisher Frontier Developments (FDEV:AIM), sold 35,000 shares at £14 on 11 November, equating to £490,000.Following the transaction Gammon holds 245,000 shares in the company which represents 0.6% of the share capital.Frontier reported record revenues (21 Sep) for the year to 31 May up 26% year-on-year to £114 million driven by the successful

The FTSE 100 closed higher on Friday, ignoring declines in US stocks as inflation, looming interest rate hikes and weak jobs report spooked investors across the pond.At the close, the UK benchmark index had rallied 0.47% to hit 7,485.28, although the mid-cap FTSE 250 lost further ground, down 0.27% to finish at 23,353.25.'Although today's jobs report shows yet another disappointing top line jobs n

Major UK stocks are struggling for direction at lunchtime on Friday with European markets a mixed bag, and while mid-cap sellers are out in force investors may take some comfort that futures are pointing to US markets finishing on the front foot after a turbulent week.At 12pm, the benchmark FTSE 100 was just a touch south of flat at 7,448.84, roughly matching the 0.07% decline of the pan-European

UK stocks drifted in early trading as investors awaited the next piece of US economic data, the December non-farm payrolls report due at lunchtime. A stronger than expected number could be negative for markets as it adds to worries the US Federal Reserve will raise rates earlier than expected.There was positive news in the technology sector with Samsung Electronics, a major Asian chipmaker, and ST

FTSE closed lower on Friday as worries over spiking energy costs added to concerns about the slowing pace of recovery. However, the index of leading shares managed its first weekly gain since mid-August.COMPANY ROUND-UPDrug maker AstraZeneca (AZN) said its prostate cancer drug in combination with abiraterone developed with MSD, had met the primary goal of a phase 3 trial. Its shares advanced 2% to

A combination of weak UK consumer confidence, renewed fears about the Evergrande crisis and fretting about the outlook for interest rates put the FTSE 100 on the back foot on Friday.By midday the index was down 0.15% to 7,067.88.Drug maker AstraZeneca (AZN) said its prostate cancer drug in combination with abiraterone developed with MSD, had met the primary goal of a phase 3 trial trial. It shares

Science equipment manufacturer Judges Scientific (JDG:AIM) surged 7.2% to £75.05 as it hiked its first-half dividend after lifting its annual outlook amid an ongoing recovery from the pandemic.'Our financial position is robust and the board has confidence that the performance for the year as a whole will be ahead of consensus expectations,' the company said.The upgraded guidance came alongside st

AIM-traded SDI (SDI:AIM) represents a multi-year growth story with the potential to add substantial value to retail investor portfolios.It is a collection of multiple subsidiaries that design and manufacture digital imaging, sensing and control equipment used in life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation applications.SDI operates a model closely rese

Many Brits have seen their incomes remain much the same through the year of lockdowns but their spending plummet. It's time to put that spare money to work in an ISA.Investing spare cash is a sensible option for many people. Take George, for example. He put £10,000 in a Cash ISA account five years ago on a fixed 2% a year interest rate. At the same time, his sister Mildred also decided to put £1

Science and technology kit designer SDI (SDI:AIM) will crush pre-existing financial performance forecasts this year and next after securing 'material' follow-on orders for its Atik cameras business.The order comes from a major original equipment manufacturer (OEM) of real-time PCR DNA amplifiers, after an initial contract won by SDI in 2020.Delivery timing of orders remains up in the air but the c

Retail logistics specialist Clipper Logistics (CLG) has had a storming run over the past year with its share price more than doubling as the firm has grown revenues and earnings significantly during lockdown.Its executive chairman Steve Parkin appears to have taken advantage of that after Carlton Court Investments, a company ultimately controlled by Parkin, sold 11 million shares at 575p each in t

Science equipment maker Judges Scientific (JDG:AIM) saw business demand bounce back strongly in the second half of 2020, and the company now expects annual adjusted earnings per share (EPS) to top market expectations.Consensus forecasts had been pitched at 151.8p of EPS for the year to 31 December 2020 but analysts are now recalculating spreadsheets.'The performance confirmed pulls through a circa

As the UK continues to step lightly through the coronavirus pandemic's social distancing minefield, many investors have turned their back on the small cap space. This is a mistake.We can understand why small caps might not appeal to everyone at the moment, given this space can include unproven business models and fragile balance sheets. It can also be harder to sell small cap shares when you want

Sentiment towards UK stocks has dramatically improved since the December general election vote result, as evidenced by widespread gains among UK-focused funds and investment trusts.FE Fundinfo data mined by Shares shows the most obvious open-ended fund beneficiaries of the 'Boris Bounce' from across the IA UK Equity Income, IA UK All Companies and IA UK Smaller Companies sectors have been the cons

JUDGES SCIENTIFIC (JDG:AIM) £50.50Gain to date: 77.2%Original entry point: Buy at £28.50, 11 April 2019A near-80% gain in a few short years would be impressive, but to do it in just a handful of months takes luck as well as good judgement.Yet this is what's happened to the performance of Judges Scientific (JDG:AIM) since we highlighted its attractions in April.The company is a portfolio of niche

We live in a world of climate change, ageing populations, pressure on food and water supplies and depleting raw materials. Against these substantial challenges we look to science and technology to provide solutions, and Oxford Instruments (OXIG) hands the boffins the technology tools.The FTSE 250 member is among the world leaders in its field, providing equipment to global industrial companies and

JUDGES SCIENTIFIC (JDG:AIM) £38.30Gain to date: 68%Original entry point: Buy at £22.80, 11 April 2019Half year results delivered everything investors could have desired, underlining once again how science kit maker Judges Scientific (JDG:AIM) is a high quality business.New first-half records were set for revenue, adjusted pre-tax profit, earnings per share, cash generation and dividends, the lat